Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Molecular Biology Reports|March 27, 2014
No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek populationE Giannakopoulou, G Ragia, V Kolovou, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 27, 2001
Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levelsI Skrapari, D Perrea, I Ioannidis, et al.
Journal of Lipid Research|June 19, 2009
Persistence of an atherogenic lipid profile after treatment of acute infection with BrucellaF Apostolou, I F Gazi, A Kostoula, et al.
Atherosclerosis|July 3, 2010
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changesF Apostolou, I F Gazi, K Lagos, et al.
Journal of Thrombosis and Haemostasis : JTH|September 1, 2005
Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to plateletsA Kouki, J V Mitsios, M Sakarellos-Daitsiotis, et al.
Surgical Endoscopy|July 10, 2001
Lipid peroxidation and the use of emulsified propofol in laparoscopic surgeryA D Manataki, A D Tselepis, G K Glantzounis, et al.
Journal of Human Hypertension|December 2, 2011
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertensionL G Christogiannis, M S Kostapanos, C C Tellis, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2011
Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapyA D Tselepis, M E Tsoumani, K I Kalantzi, et al.
Clinical and Experimental Rheumatology|December 3, 2010
Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatmentC S Derdemezis, T D Filippatos, P V Voulgari, et al.
Scandinavian Journal of Rheumatology|January 15, 2013
Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot studyT D Filippatos, C S Derdemezis, P V Voulgari, et al.
Pageof 6